Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Cheng Lee

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Plos One|November 28, 2017
Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failureI-Cheng Lee, Gar-Yang Chau, Yi-Chen Yeh, et al.
Cancers|April 23, 2022
Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular CarcinomaI-Cheng Lee, Yee Chao, Pei-Chang Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|November 28, 2019
Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in TaiwanChen-Ta Chi, Chi-Yi Chen, Chien-Wei Su, et al.
Liver Cancer|December 24, 2021
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven CriteriaYa-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.
Liver Cancer|February 12, 2024
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular CarcinomaYa-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.
Journal of Hepatology|July 31, 2024
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapyHsien-Chen Mon, Pei-Chang Lee, Yi-Ping Hung, et al.
The Journal of Infectious Diseases|May 10, 2018
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up StudyI-Cheng Lee, Sien-Sing Yang, Chieh-Ju Lee, et al.
Liver Cancer|March 27, 2025
M2BPGi Correlated with Immunological Biomarkers and Further Stratified Recurrence Risk in Patients with Hepatocellular CarcinomaI-Cheng Lee, Hao-Jan Lei, Lei-Chi Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 21, 2019
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resectionShih-Hao Young, Gar-Yang Chau, I-Cheng Lee, et al.
Medicine|December 4, 2015
The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in TaiwanChi-Lung Tseng, Wei-Jen Lai, Chun-Jui Huang, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Plos One|November 28, 2017
Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failureI-Cheng Lee, Gar-Yang Chau, Yi-Chen Yeh, et al.
Cancers|April 23, 2022
Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular CarcinomaI-Cheng Lee, Yee Chao, Pei-Chang Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|November 28, 2019
Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in TaiwanChen-Ta Chi, Chi-Yi Chen, Chien-Wei Su, et al.
Liver Cancer|December 24, 2021
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven CriteriaYa-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.
Liver Cancer|February 12, 2024
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular CarcinomaYa-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.
Journal of Hepatology|July 31, 2024
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapyHsien-Chen Mon, Pei-Chang Lee, Yi-Ping Hung, et al.
The Journal of Infectious Diseases|May 10, 2018
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up StudyI-Cheng Lee, Sien-Sing Yang, Chieh-Ju Lee, et al.
Liver Cancer|March 27, 2025
M2BPGi Correlated with Immunological Biomarkers and Further Stratified Recurrence Risk in Patients with Hepatocellular CarcinomaI-Cheng Lee, Hao-Jan Lei, Lei-Chi Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 21, 2019
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resectionShih-Hao Young, Gar-Yang Chau, I-Cheng Lee, et al.
Medicine|December 4, 2015
The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in TaiwanChi-Lung Tseng, Wei-Jen Lai, Chun-Jui Huang, et al.
Pageof 7